摘要 ： 近日，香港城市大学（东莞）发布多批政府采购意向，仪器信息网特对其中的仪器设备品目进行 梳理，统计出23项仪器设备采购意向，预算总额达2.10亿元。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 近日，香港城市大学（东莞）发布2 3项仪器设备采购意向，预算总额达2 . 1 0亿元，涉及智能制 造工程、生物医学工程、能源与动力工程、微加工平台等实验设备，预计采购时间为2 0 2 5年2 月~2 0 2 6年6月。 详细采购清单： 香港城市大学（东莞）2 0 2 5年2月~ 2 0 2 6年6月 仪器设备采购 意向汇总表 | | | | 采 | | --- | --- | --- | --- | | 采购 | 需求概况 | 预算 | 购 | | 项目 | | 万元 | 时 | | | | | 间 | | 电子 | 标的名称:电子资讯工程科研设备 标的数量:1 主要功能或目 | | 202 | | 资讯 | 标:为学校研究人员开展科研提供支撑。 需满足的要求:l）供 | | 6 | | 工程 | 应商参加政府采购活动前三年内，在经营活 ...

Group 1: Industry Overview - The Hong Kong Trade Development Council (HKTDC) reports that Hong Kong is collaborating with Guangdong and Macau to advance technological innovation in the Greater Bay Area, with biomedicine emerging as a key industry cluster [1] - The number of biomedical companies in Hong Kong has increased significantly from 2,340 in 2013 to 3,020 in 2023, indicating robust growth in the sector [1] - The Guangdong provincial government aims to accelerate the development of the biomedicine industry, targeting a cluster scale exceeding 1 trillion RMB by 2027, up from 664 billion RMB in 2023, representing a 50% increase [1] Group 2: Financial Landscape - As of June 30, 2025, the total market capitalization of the healthcare sector listed in Hong Kong is $441 billion, accounting for approximately 8.1% of the total market capitalization of listed companies in Hong Kong, a threefold increase from $144 billion at the end of 2017 [2] - There are currently 73 biotech companies listed under the 18A regime, having raised a total of $16 billion [2] - Hong Kong's advanced clinical trial capabilities and internationally recognized clinical trial data position it as an ideal location for expanding global biomedicine businesses [2] Group 3: Startup Ecosystem - The number of biotech and health tech startups in Hong Kong has surged from 110 in 2018 to 510 in 2024, increasing their share of total startups from 4% to 11%, outpacing other startup sectors [3] - These startups are involved in various cutting-edge fields, including new drug development, gene editing technology, medical device innovation, and precision medical solutions [3]

Group 1 - The "Shenzhen-Hong Kong-Guangzhou" innovation cluster ranks first in the 2025 Global Innovation Index, surpassing the "Tokyo-Yokohama" cluster which held the top position for five consecutive years [1] - The "Shenzhen-Hong Kong-Guangzhou" cluster is ranked 45th in innovation intensity, while the "Macau-Zhuhai" cluster, which debuted in 2024, has risen to 98th place and is ranked 81st in innovation intensity [1] - The Greater Bay Area's innovation landscape is characterized by the active collaboration between the Guangzhou-Shenzhen-Hong Kong and Guangzhou-Zhuhai-Macau corridors, with the latter becoming a hub for technology cooperation [1] Group 2 - A number of innovation platforms are emerging along the Guangzhou-Zhuhai-Macau corridor, including the China-Portuguese-speaking Countries Technology Exchange and Cooperation Center in Macau and the Zhuhai-Hengqin Center, both of which are fully operational [2] - The Guangdong-Hong Kong-Macau Greater Bay Area Development Plan emphasizes the construction of an international technology innovation center, aiming to deepen innovation cooperation and create a collaborative innovation community [2] - The plan focuses on gathering international innovation resources, optimizing the innovation policy environment, and enhancing the ability to transform scientific and technological achievements into practical applications [2]